| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/03/2005 | WO2005003098B1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/03/2005 | WO2004103309A3 Immunosuppressant compounds and compositions |
| 03/03/2005 | WO2004083173A3 Ketopiperazine derivatives as bradykinin antagonists |
| 03/03/2005 | US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders |
| 03/03/2005 | DE10336186A1 Sulfonamid-Anionen als Katalysatoren für die NCO-Oligomerisierung Sulfonamide anions as catalysts for the NCO oligomerization |
| 03/03/2005 | CA2536313A1 Fused pyrimidine derivative and use thereof |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1191248C 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype lignds |
| 02/24/2005 | WO2005017037A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | WO2005016897A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | WO2005016896A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 02/24/2005 | WO2005016879A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 02/24/2005 | WO2005016876A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016342A1 Sir2 regulation |
| 02/24/2005 | WO2005016286A2 Pyrazine modulators of cannabinoid receptors |
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016000A1 Derivatives of cyclic quinone and uses thereof |
| 02/24/2005 | US20050043552 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043313 1-(phenylaminocarbonylmethyl)-3-alkylamino-5,6-disubstituted-2-pyazinones; serine protease inhibitors; anticoagulants; coronary artery and cerebrovascular diseases |
| 02/24/2005 | US20050043310 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits |
| 02/24/2005 | CA2536073A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535652A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | CA2531253A1 Sir2 regulation |
| 02/23/2005 | EP1507768A1 Aryl-alkyne compounds as herbicides |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1226128B1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/22/2005 | US6858744 Heterocyclic ester such as quinoxaline-2-carboxylic acid (4(R) -carbamoyl-1(S)-(3-fluoro-benzyl)-2(S),7-dihydroxy-7-methyl-octyl)-amide, used as preferential antagonists of macrophage inflammatory proteins |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858611 Antiarrhythmia agents; cardiovascular disorders |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858600 Used for inhibiting the interaction of an alpha-helical protein with another protein or binding site; for therapy of diseases |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004084813A3 Chemical compounds |
| 02/17/2005 | US20050038255 Stereoselective preparation of cyclic l-amino acids |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038032 Quinoxaline compounds |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/16/2005 | EP1068200B1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 02/16/2005 | CN1189462C Catalyst for synthesizing 2-cyano pyrazine from 2-methy/pyrazine and synthesizing method |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | US20050033005 Sulfonamide anions as catalysts for NCO oligomerization |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
| 02/09/2005 | EP1503999A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1188402C Piperazinone derivs. and their uses |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852855 Synthesis of piperazine ring |
| 02/08/2005 | US6852723 Aralkyl substituted piperazine compounds |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009979A1 Quinoxaline derivative and luminescent element comprising the same |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | WO2004085384A3 Bis-aryl sulfonamides |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050027007 Allylamides useful in the treatment of alzheimer's disease |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/03/2005 | DE10332560A1 New beta-heteroaryl-alpha-alanine compounds, used as intermediates in synthesis of biologically active peptides |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/02/2005 | EP1501898A1 Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |